AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tubitere 80mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Docetaxel (80mg)

Overview Tubitere 80mg Injection

Oncaspar 80mg Injection is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined individually by your physician, depending on your specific cancer and may be adjusted. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months; discontinue use only under your doctor's guidance. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor may prescribe additional medication to mitigate these. Report any unexplained bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, and any other medications, including antibiotics, you are taking. Numerous drug interactions are possible; disclose all medications. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout treatment to prevent conception.

Uses of Tubitere 80mg Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Tubitere 80mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Tubitere 80mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Tubitere 80mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Tubitere 80mg Injection works:

The anticancer drug, Tubitere 80mg Injection, disrupts microtubule formation, essential for cancer cell division and proliferation. This mechanism inhibits cancer cell growth, ultimately leading to their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Tubitere 80mg Injection is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Tubitere 80mg Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might prescribe it when the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Lactation and Tubitere 80mg Injection are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

Tubitere 80mg Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The 80mg Tubitere injection presents no safety concerns for patients with renal impairment; dose modification is unnecessary.

LiverLiverCAUTION

For individuals with hepatic impairment, administration of Tubitere 80mg Injection requires careful monitoring. Dosage modification of Tubitere 80mg Injection might be necessary. Physician consultation is recommended.

What if you forget to take Tubitere 80mg Injection :

NA

Facts to Know About Tubitere 80mg Injection

LabelValue
Type of Compound Taxane-based medications
Addictive None.
Medication Category Cancer therapies
Mechanism of Action Microtubule-disrupting drugs: Taxane class

FAQs on Tubitere 80mg Injection

Tubitere 80mg Injection can lead to weight increase, often beginning with fluid retention causing foot swelling that may subsequently affect the entire body. Contact your physician promptly if you experience foot edema.
Maintain Tubitere 80mg Injection administration according to your physician's instructions. Treatment length depends on your specific cancer and individual response. Infusions are typically administered every three weeks.
Tubitere 80mg Injection includes alcohol as an ingredient; consequently, you might experience drowsiness, disorientation, unsteady gait, or a sensation of intoxication. This could compromise your ability to operate vehicles or machinery immediately following administration. Therefore, refrain from alcohol consumption while undergoing Tubitere 80mg Injection treatment to prevent potentially harmful interactions.
The injectable medication Tubitere 80mg is frequently administered in the treatment of breast cancer, specific lung cancers, prostate cancer, stomach cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Tubitere 80mg Injection is administered intravenously as a liquid solution by healthcare professionals in a clinical setting. The typical dosage regimen involves a single infusion over 60 minutes, repeated every 21 days.
Before each Tubitere 80mg Injection, your physician will require blood work. This includes tests like a complete blood count and liver function tests to monitor your blood cell levels and liver health, ensuring suitability for the injection. Low white blood cell counts can lead to fever or infections.
Alopecia is a frequently reported adverse reaction associated with Tubitere 80mg Injection. Hair regrowth typically occurs following discontinuation of Tubitere 80mg Injection. Nevertheless, irreversible hair loss can sometimes result. Seek medical advice if you experience hair loss concerns.
Administration of Tubitere 80mg Injection can lead to edema (swelling in the extremities) and serious allergic reactions. Prophylactic corticosteroids (dexamethasone) are provided to all patients for three days, commencing one day before Tubitere 80mg Injection is given, to mitigate these risks. For patients with metastatic castration-resistant prostate cancer, the recommended dexamethasone regimen is oral administration at 12, 3, and 1 hour prior to Tubitere 80mg Injection infusion.
The taxoid-class anticancer medication Tubitere 80mg Injection inhibits cancer cell proliferation and metastasis.
Tubitere 80mg Injection
9,086
MRP 10,542
13% off